FDA Approved: OPZELURA — Original Application (Incyte Corporation)

View source ↗

Summary

FDA approved OPZELURA (ruxolitinib) cream as the original approval for the topical treatment of atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Opzelura (ruxolitinib)

Snippet

ORIG AP for OPZELURA (RUXOLITINIB)